Inosln

The InosIn research project aims to identify pathogens in respiratory tract infections early and precisely in order to improve treatment and prevent resistance. Currently, the identification of pathogens takes up to five days, which leads to longer hospital stays, higher costs and an increased risk of complications such as sepsis. The aim is to develop and validate a new type of analysis system, a GC-IMS (gas chromatograph coupled with an ion mobility spectrometer), which uses the patient's exhaled air to identify the bacterium causing the infection non-invasively and within a very short time.

The pathogen is identified by measuring volatile organic compounds (VOCs) in the exhaled air. Rapid identification means that effective pathogen-specific antibiotic therapy can be started at an early stage. This should speed up recovery, avoid complications and reduce costs in the healthcare system.